Megakaryopoesis and platelet genesis
Authors:
M. Pecka
Authors place of work:
Oddělení klinické hematologie II. interní kliniky LF UK a FN a Katedra vnitřního lékařství LF UK Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc.
Published in the journal:
Vnitř Lék 2012; 58(7 a 8): 152-154
Category:
60. narozeniny prof. MUDr. Miroslava Penky, CSc.
Summary
Similar to other haematopoietic cells, megakaryocytes originate from haematopoietic stem cells. Proliferation and maturation of the megacaryotic cell line is stimulated by a number of factors. This process is different in progenitor and precursor cells. Towards the end of their development, mature megakaryocytes are transferred and are localized near the bone marrow sinus wall. „Proplatelets“ are formed in cytoplasmic extensions of megakaryocytes and are subsequently separated from parental megacaryocyte and transformed into platelets in the circulation.
Key words:
thrombocytes – megakaryopoesis – thrombopoesis
Zdroje
1. Mattia G, Vulcano F, Milazzo L et al. Diferent ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 2002; 99: 888–897.
2. Chang Y, Bluteau D, Debili N et al. From hematopoietic stem cells to platelets. J Thromb Haemost 2007; 5 (Suppl 1): 318–327.
3. Italiano JE Jr, Patel-Hett S, Hartwing JH. Mechanics of proplatelet elaboration. J Thromb Haemost 2007; 5 (Suppl 1): 18–23.
4. Roy L, Coullin P, Virat N et al. Asymmetrical segregation of chromosomes with a normal metaphase/anaphase checkpoint in polyploid megakaryocytes. Blood 2001; 97: 2238–2247.
5. Bessis M. Blood smears reinterptered (transl. Brechner G). Berlin, Heidelberg: Springer-Verlag 1977: 129–144.
6. Bain BJ, Clark DM, Wilkins BS. Bone marrow pathology. 4th ed. Wiley-Blackwell 2010: 20–26.
7. Hartwig J, Italiano J JR. The birth of the platelet. J Thromb Haemost 2003; 1/3: 1580–1586.
8. Schwer H, Lecine P, Tiwari S et al. A lineage-restricted and divergent beta-tubulin isoform is Essentials for the biogenesis, structure and fiction of mammalian blood platelets. Curr Biol 2001; 11: 579–586.
9. Barkalow K, Italiano JE jr, Matsuoka Y et al. Alfa-Adducin dissociated from F-actin filaments and spectrin during platelet activation. J Cell Biol 2003; 161: 557–570.
10. Radley JM, Scurfield G. The mechanism of platelet repase. Blood 1980; 56: 996–999.
11. Buliková A, Kissová J, Antošová M et al. Dysplastické změny megakaryopoézy podle WHO klasifikace 2008. Vnitř Lék 2010; 56 (Suppl 1): 531–538.
12. Yamanaka M. Blood platelets. Kobe: Sysmex corporation 2000.
13. Li J, Kuter DJ. The end is a just the beginning: megakaryocyte apoptosis and platelet release. Int J Hematol 2001; 74: 365–374.
14. Chen J, Herceg-Harjacek L, Groopman JE et al. Regulation of platelet activation in vitro by c-Mpl ligand, trombopoietin. Blood 1995; 86: 4054–4062.
15. Yang C, Li YC, Kuter DJ. The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat. Br J Haematol 1999; 105: 478–485.
Štítky
Diabetológia Endokrinológia Interné lekárstvoČlánok vyšiel v časopise
Vnitřní lékařství
2012 Číslo 7 a 8
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Význam hydratace při hojení ran
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Infarkt myokardu v mladom veku – naše výsledky a skúsenosti
- Požadavky na předoperační vyšetření z pohledu anesteziologa
- Megakaryopoéza a geneze destiček
- Antagonisty aldosterónu v liečbe chronického srdcového zlyhávania